ArticleBMJ open2026

What are the views of cancer care administrators and clinicians in England on the use of a machine learning clinical decision support system (ML-CDSS) to predict patients' risk of hepatic and renal deterioration during chemotherapy? A qualitative study.

Angelo Ercia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.